Reducing exposure to endocrine-disrupting chemicals in pregnant and lactating women and their offspring: The HYPIEND randomized controlled trial

Published March 16, 2026 | Version v1

Poster Open

1. Department of Development and Regeneration, KU Leuven, Leuven, Belgium
2. Department of Legal Medicine, Toxicology and Physical Anthropology, University of Granada (UGR), Granada, Spain
3. Department of Gynaecology and Obstetrics, Germans Trias i Pujol Research Institute (IGTP), Barcelona, Spain
4. Department of Paediatrics, Germans Trias i Pujol Research Institute (IGTP), Barcelona, Spain
5. Department of Lifestyle Medicine, Centre for Postgraduate Medical Education (CMKP), Warsaw, Poland
6. Department of Obstetrics and Gynaecology, Centre for Postgraduate Medical Education (CMKP), Warsaw, Poland
7. Eurecat, Centre Tecnològic de Catalunya, Biotechnology Area, Reus, Spain

Files

Name	Size	Download all
Poster_BASO_2026_HYPIEND.pdf md5:f649ccb27eef52c8c7649217c6678a84	602.9 kB	Preview Download

European Commission
HYPIEND - Understanding and preventing the impact of endocrine disruptors on the hypothalamus-pituitary axis in sensitive populations 101137440

Schulz MC, Sargis RM. Inappropriately sweet: Environmental endocrine-disrupting chemicals and the diabetes pandemic. Adv Pharmacol [Internet]. 2021 Jan 1 [cited 2024 Jun 6];92:419–56. Available from: https://pubmed.ncbi.nlm.nih.gov/34452693/
Heindel JJ, Howard S, Agay-Shay K, Arrebola JP, Audouze K, Babin PJ, et al. Obesity II: Establishing causal links between chemical exposures and obesity. Biochem Pharmacol [Internet]. 2022 May 1 [cited 2024 Jun 6];199. Available from: https://pubmed.ncbi.nlm.nih.gov/35395240/
O'Shaughnessy KL, Fischer F, Zenclussen AC. Perinatal exposure to endocrine disrupting chemicals and neurodevelopment: How articles of daily use influence the development of our children. Best Pract Res Clin Endocrinol Metab [Internet]. 2021 Sep 1 [cited 2024 Jun 6];35(5). Available from: https://pubmed.ncbi.nlm.nih.gov/34565681/